INOVIO Says FDA Grants Breakthrough Therapy Designation For INO-3107; Stock Up 15%

Logo NasdaqNasdaq
2023-09-07 12:14:04  • 2 mins

(RTTNews) - Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Thursday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for INO-3107 as a potential treatment for patients with Recurrent Respiratory Papillomatosis (RRP).

The FDA's Breakthrough Therapy designation is a process designed to expedite the development and review of drug candidates that are intended to treat a serious or life-threatening condition.

INO-3107 is an investigational DNA medicine candidate designed to elicit a targeted T cell response against HPV-6 and HPV-11, the HPV types that cause RRP and other HPV-related disease.

Continue read on

(RTTNews) - Viatris Inc. (VTRS) and Ocuphire Pharma, Inc. (OCUP) announced the FDA has approved RYZUMVI 0.75% for the treatment of pharmacologically-induced...
Logo NasdaqNasdaq
2023-09-27 12:20:00  • 1 min
Pfizer Inc's PFE CEO Albert Bourla provided an update on the status of the company's oral antiviral COVID-19 treatment, Paxlovid, during his speech at the...
Logo BenzingaBenzinga
2023-09-27 12:54:10  • 1 min
(RTTNews) - Tonix Pharmaceuticals Holding Corp. (TNXP) said the University of North Carolina Institute for Trauma Recovery has been awarded a $3 million...
Logo NasdaqNasdaq
2023-09-27 13:14:29  • 1 min
(RTTNews) - Takeda (TAK) said that the U.S. Food and Drug Administration has approved a subcutaneous or SC administration of Entyvio (vedolizumab) for...
Logo NasdaqNasdaq
2023-09-28 02:51:57  • 1 min
Inozyme Pharma Inc INZY announced interim safety, pharmacokinetic (PK), pharmacodynamic (PD), and exploratory efficacy data from its ongoing Phase 1/2 trials...
Logo BenzingaBenzinga
2023-09-26 18:43:58  • 1 min
(RTTNews) - Phathom Pharmaceuticals, Inc. (PHAT), a biopharmaceutical company focused on gastrointestinal or GI diseases, announced Tuesday the submission of...
Logo NasdaqNasdaq
2023-09-26 13:05:01  • 1 min
(RTTNews) - Bionomics Limited (BNOX) reported positive topline results from Phase 2b ATTUNE trial of BNC210 for the treatment of Post-Traumatic Stress...
Logo NasdaqNasdaq
2023-09-28 10:13:19  • 1 min
Fintel reports that on September 27, 2023, Needham reiterated coverage of Inozyme Pharma ( NASDAQ:INZY ) with a Buy recommendation. Analyst Price Forecast...
Logo NasdaqNasdaq
2023-09-28 08:18:41  • 1 min
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA) said the FDA has granted Fast Track designation to development program investigating IDE161 for the treatment of...
Logo NasdaqNasdaq
2023-09-27 10:29:47  • 1 min
Fintel reports that on September 27, 2023, Mizuho initiated coverage of CRISPR Therapeutics ( NASDAQ:CRSP ) with a Buy recommendation. Analyst Price Forecast...
Logo NasdaqNasdaq
2023-09-28 02:09:16  • 1 min
Consulting firm McKinsey & Company has reached a substantial settlement agreement of $230 million to resolve lawsuits filed by numerous U.S. local...
Logo BenzingaBenzinga
2023-09-27 12:52:04  • 1 min
WASHINGTON (AP) Federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrigs disease at a Wednesday meeting prompted by...
Logo U.S. News & World ReportU.S. News & World Report
2023-09-27 22:15:30  • 1 min
MANILA -The Philippines’ first vaccine manufacturing facility in the province of Batangas could start production in as early as two years from now, creating...
2023-09-27 18:20:00  • 1 min
(RTTNews) - ZimVie Inc. (ZIMV) announced that on September 7, 2023, the FDA approved its Mobi-C Cervical Disc Hybrid Investigational Device Exemption...
Logo NasdaqNasdaq
2023-09-26 12:45:38  • 1 min
Pliant Therapeutics Inc PLRX announced data from the INTEGRIS-PSC Phase 2a trial of bexotegrast in patients with primary sclerosing cholangitis (PSC) and...
Logo BenzingaBenzinga
2023-09-26 18:56:03  • 1 min
(RTTNews) - Evotec SE (EVO, EVOTF.PK) and Novo Nordisk A/S (NVO) announced Tuesday a translational drug discovery accelerator called LAB eN, which aims to...
Logo NasdaqNasdaq
2023-09-26 12:08:17  • 1 min
(RTTNews) - Biogen Inc. (BIIB) has completed the acquisition of Reata Pharmaceuticals, Inc. (RETA). As a result, Biogen has now acquired SKYCLARYS, and other...
Logo NasdaqNasdaq
2023-09-26 14:03:36  • 1 min
Fintel reports that on September 27, 2023, HC Wainwright & Co. maintained coverage of Pliant Therapeutics ( NASDAQ:PLRX ) with a Buy recommendation....
Logo NasdaqNasdaq
2023-09-28 02:09:30  • 1 min
U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria. More than a million...
Logo BenzingaBenzinga
2023-09-27 15:46:43  • 1 min
( Kitco News ) - It looks as though the first spot Bitcoin ( BTC ) exchange-traded fund (ETF) won’t launch until 2024 at the earliest as the Securities and...
Logo Kitco NEWSKitco NEWS
2023-09-27 16:36:34  • 1 min